A Comparative Study of Fluticasone Alone and Fluticasone with Azelastine Nasal Spray in Patients with Allergic Rhinitis
Abstract
In India, 20-30% of the population suffers from allergic rhinitis. Its prevalence increasing over the past many years and often adversely affects the quality of life. Little importance is given to allergic rhinitis and patients fail to correlate the ill-health to symptoms of allergic rhinitis in India. Studies have shown that patients with allergic rhinitis adversely affect the behavior, work performance, and lifestyle of patients. Hence this study was undertaken to compare the efficacy of fluticasone alone and in combination with azelastine. A total of 60 patients were randomly assigned into two groups (30 patients each), where the first group received fluticasone and the other group received fluticasone + azelastine. Drugs were administered as nasal spray and improvement were assessed using Total Nasal Symptom Score (TNSS) and Quality of life was assessed using Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) at baseline and at 2 weeks. Descriptive statistics and student’s t-test was used to analyze data. Both the groups had statistical improvement in TNSS and RQLQ scores when compared to baseline within the groups (p < 0.0001). Comparison of overall TNSS between the groups was statistically significant (p < 0.001), though total RQLQ scores were insignificant (< 0.02) when compared between two groups. It was observed that both drugs were safe and efficacious. By these results, we conclude that the combination therapy showed better improvement in TNSS when compared to fluticasone alone. Azelastine due to antihistaminic properties and fluticasone anti-inflammatory effect showed synergistic anti-inflammatory effect and improvement in quality of life
Keywords
Full Text:
PDFReferences
Glenis S, Stephen D.Allergic Rhinitis. In Michael G, George GB editors Scott-Brown’s Otolaryngology, Head and Neck Surgery.7th edition Great Britain: Hodder Arnold 2008, Vol 2. P.1386-1407.
Meltzer EO. Quality of life in adults and children with allergic rhinitis. Journal of Allergy and Clinical Immunology. 2001; 108(1):45-53.
Chandrika D. Allergic rhinitis in India: an Overview. International Journal of Otorhinolarynglogy Head and Neck Surgery. 2017; 3(1):1-6.
Hansen J, Klimek L, Hormann K. Pharmacological management of allergic rhinitis in elderly: safety issues with oral antihistamines. Drugs Aging. 2005; 22: 289-296.
Bousquet J, Van Cauwenberge P, Ait Khaled N et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update. Allergy. 2006; 61: 1086-1096.
Strokes M, Amorosi SL, Thompson D et al. Evaluation of patients preferences for Triamcinolone acetonide aqueous, Fluticasone propionate and Mometasonefuroate nasal spray in patients with allergic rhinitis. Otolaryngology Head and Neck Surgery. 2004; 131: 225-231.
Bernstein JA. Azelastinehydrochloride : a review of pharmacology,pharmacokinetics, clinical efficacy and tolerability. Current Medical Research and Opinion. 2007; 23: 2441-52.
Bousquet J, Khaltaev N, Cruz AA et al .Allergic rhinitis and its impact on asthma (ARIA). Allergy. 2008; (86):8–160.
Barnes PJ. Pulmonary pharmacology. In: Brunton LL, Dandan RH, Knollmann BC editors. Goodman and Gilman’s Pharmacological Basis of Therapeutics. 13thed. New York
Skidgel RA. Histamine, Bradykinin and their antagonists. In: Brunton LL, Dandan RH, Knollmann BC editors. Goodman and Gilman’s Pharmacological Basis of Therapeutics. 13thed. New York
Varshney J, Varshney H. Allergic Rhinitis: an Overview. Indian Journal of Otolaryngology Headand Neck Surgery 2015; 67(2):143-149.
Ratner P, Sacks H. Randomized double blind trial of Azelastine nasal spray plus Fluticasone nasal spray compared to either agent alone in patients with allergy to Texas Mountain Cedar. Annals of Allergy Asthma and Immunology. 2008; 100(1):74-81.
Hampel FC, Ratner PH, Van Bavel J. Double blind placebo controlled study of Azelastine and Fluticasone in a single nasal spray delivery device. Annals of Allergy Asthma and Immunology 2010; 105(2):168-73.
Behncke VB, Alemar GO, Kaufman DA, et al. Azelastine nasal spray and Fluticasone nasal spray in treatment of geriatric patients with rhinitis. Journal of Allergy and Clinical Immunology 2006; 117-263.
Sami AS, Ahmed N, Ahmed S. The effect of novel combination therapy with Azelastine hydrochloride and Fluticasone propionate in Allergic Rhinitis. Otolaryngology 2016; 6(4)1-8.
Dhanush HC, Malashetti S, Chandrashekharayya SH,KhavasiP. Comparative study of fluticasone propionate combined with azelastine versus fluticasone propionate alone as nasal spray in allergic rhinitis. International Journal of Otorhinolaryngology Head Neck Surgery 2021; 7:487-92.
Salib JR, Howarth PH. Safety and tolerability profiles of intranasal antihistaminic and intranasal corticosteroids in treatment of allergic rhinitis. Drug Safety 2006; 26:863-93.
Nielsen LP, Dahl R. Comparison of intranasal corticosteroids and antihistaminics in allergic rhinitis. American Journal of Respiratory Medicine 2003; 2:55-56.
Bhadouriya SKS, Srivastava M, Saxena R, Srivastava A. Comparative clinical evaluation of effect of topical verses systemic anti-allergic drug in allergic rhinitis: a prospective study. International Journal of Otorhinolaryngology Head Neck Surgery. 2018; 4:141-7.
Dalvi R, Havle AD. Comparitive analysis of treatment of allergic rhinitis utilising azelastine and fluticasone. International Journal in Research and Pharmaceutical Sciences. 2020;11(3):4636-43
DOI: https://doi.org/10.15416/pcpr.v6i3.33204
Refbacks
- There are currently no refbacks.
